Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 101.33B | 95.57B | 88.42B | 102.30B | 101.20B | 86.67B |
Gross Profit | 21.18B | 21.25B | 21.07B | 22.69B | 21.89B | 20.14B |
EBITDA | 8.51B | 9.59B | 8.89B | 7.66B | 12.02B | 9.79B |
Net Income | 4.79B | 4.59B | 3.39B | 2.44B | 5.56B | 3.25B |
Balance Sheet | ||||||
Total Assets | 89.18B | 79.75B | 82.13B | 89.61B | 92.73B | 123.42B |
Cash, Cash Equivalents and Short-Term Investments | 8.14B | 3.63B | 7.37B | 8.61B | 9.48B | 9.51B |
Total Debt | 28.69B | 24.57B | 25.99B | 29.59B | 26.95B | 41.45B |
Total Liabilities | 91.94B | 81.13B | 84.26B | 92.64B | 94.31B | 115.39B |
Stockholders Equity | -2.77B | -1.48B | -2.23B | -3.12B | -1.69B | 2.95B |
Cash Flow | ||||||
Free Cash Flow | 4.86B | 1.87B | 5.92B | 562.00M | 7.51B | 9.32B |
Operating Cash Flow | 7.48B | 4.52B | 8.68B | 3.56B | 10.31B | 11.41B |
Investing Cash Flow | -1.95B | -2.21B | -2.78B | -3.02B | 1.31B | -460.00M |
Financing Cash Flow | -1.93B | -5.82B | -7.09B | -1.63B | -16.61B | -5.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $24.04B | 21.28 | 123.00% | 1.76% | 3.45% | 9.69% | |
74 Outperform | $43.46B | 25.97 | 25.98% | 0.17% | 2.12% | ― | |
72 Outperform | $51.71B | 37.34 | -109.27% | 1.28% | 38.86% | 337.22% | |
66 Neutral | $24.87B | 9.69 | 84.33% | 4.36% | 3.11% | -3.54% | |
65 Neutral | $98.01B | 20.70 | -179.12% | 1.29% | 10.68% | 24.29% | |
65 Neutral | $29.69B | 221.83 | 10.04% | ― | 11.31% | -1.30% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |